Relpax tablets film-coated

Country: Armenia

Bahasa: Inggeris

Sumber: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Bahan aktif:

eletriptan (eletriptan hydrobromide)

Boleh didapati daripada:

R-Pharm Germany GmbH

Kod ATC:

N02CC06

INN (Nama Antarabangsa):

eletriptan (eletriptan hydrobromide)

Dos:

40mg

Borang farmaseutikal:

tablets film-coated

Unit dalam pakej:

(2) in blister

Jenis preskripsi:

Prescription

Status kebenaran:

Registered

Tarikh kebenaran:

2018-01-10

Ciri produk

Ir+!@.er$r-,*,rcasff
P,,RsDu
T
Relpx
40
mg
Film-caated
Tabl,ers
s
P*ii;?igIj
i'i:'-.
-,,.*,;
j,$[
TXFtgTtilATA-
Sf.It'$r
F+
t"-l?-17
!]i
t i
!ilT
ii
i
T
{fiorLi:-rrJ.1!
L
QUAtrfA$if
reu
x.ntr+,yrw
coMposlTroN
,.,,,
',,.'...
:
,
,'.
:
Eaeh
fihn-coared
iatl;
iontains:
Aetive
ingredient:
eletriptzui
hydrobromide
48,485
mg
(equiuatenr
ro
40 mg
of
eleriptan);
For
the
futl
tiit
of
excipients.
see
secrion
6.
|
.
3,
,
,,F.I{eRltreCtrUTICAt
FOiBn{
40
mg tablets:
o.ranqe
round
bieonvex
ftlm:coated
tablets
debossed
with
"REP
40"
on one side
and
,'pfrzer'i
on
the
otirer.
4.
!f;l
CLINICAL
PARTICULARS
Therapeutic
in
dications
Relief
of
migraine
attacks
with
or
rittiout
auia.
:
Fosology
and
method
of
administration
Oral
route.
Tlre tablets
shoirld
be
swatlowed
whole
with
water.
Relpax@
tablets-should
lre
taken
as
early
as
possible
afler
the
orrset
of migraine
headache
but
they
are
also
eff'ective
iftakpn
at
a
later
stAge.
Adrrlls (18;65
years)
Tlle rccomm*nciO
ini*"i
dose
is
40
mg.
Weadache
returns
wllhin
24
howis:
If
migraine
headache
is
relieved
but then
recurs
within
24
hours,
an
additional
dose
of
the,
sarne
strength
of
Relpaxo
may
be
admiiristered.
lf
a
second
dose is
required,
it
should not
be
taken
within
2
hours
oithe
initial
rjose.
If
no response
is
obtained:
If
a
patient
does
not
achieve
a
headache respo{ise
to
the first
dose
ot"
lulp**
within
2
hours,
a
second
dose
should
not
be
taken
for
the
same
attack
as
ctinical
trials
hal,:|;,not
eqtrate
l
e,s
isaedte,ffie'tcy..with
the
ngCong
dose.
The,pbrients
wlro
do
not
respond,
tb
the
trear,q
nf of,an.attack
wilJ.r,esppnd.tii,*e.f
nt
ofarsu,bsbquent
atrack.
'
,
Patients
who
dp not
obtain
satisfactory
efficacy
with
40
mg
may
be
effictive
ly
treated
with
80
mg
in
a
subsequent
rnigraine
attac[.
The
daily
dose
shorrld
rrot
**""ra
160 rng.
Patients
rvith
rnild
ot
modetate
llepatic
inrpairment
do
not
requile
rlre
dose
adjustmenr.
Contraindications
Hypersansitivity
to eletriptan
or
any
other
component
of
the product.
4;
4j
\
:r
:'
,'::-
/2
rz
/7
Severe
hepatic
inrpairmeni..
Age
un